HysensBio
PrivateLast Round
Private Equity
Feb 1, 2026
Est. Valuation
$75.9M
Total Funding Raised
$21.57M
Company Overview
HysensBio is a drug discovery company that develops dental treatment technology using a cell activation platform to provide therapies for dentin hypersensitivity and dental caries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HysensBio Comparables
Compare HysensBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mintech-Bio | 78% | |
| Stemden | 77% | |
| Toregem BioPharma | 74% | |
HysensBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 1, 2026 | ||||
| VC Round | Jul 24, 2023 | ||||
| Series C | May 7, 2021 | ||||
| Series B | May 29, 2019 | ||||
| Series A | Mar 1, 2018 |
HysensBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DAYLI Partners | Series B |
| Korea Investment Partners | Private Equity, Series B, Series A, Series C |
| KB Investment | Private Equity, VC Round |
| DS Asset Management | Series C, VC Round |
| Timefolio Asset Management | Series B, Series C |
| KTB Ventures | Series C |
| Daol Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Won Pitch Competition at ADA Forsyth dentech 2025.
- Jan 1, 2025
Attended the Pitch Competition at ADA Forsyth dentech 2025.
HysensBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HysensBio's valuation, stock price, and market status.